https://hydroxylasesignaling.c....om/index.php/serious
A retrospective analysis of 49 out of 72 participants diagnosed with diffuse glioma, who underwent CEST MRI at 3T between July 2018 and December 2021, 4 to 6 weeks post-radiotherapy completion, was performed. The volumes of contrast-enhancing tumor (CE) and whole tumor (WT) were determined by segmentation on T2w-FLAIR and contrast-enhanced T1w images. Statistical methods comprising Kaplan-Meier analysis and logrank testing were used. The association between OS and APTw imaging was the